NM Coordinating Committee: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
mNo edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
Co-Chairs: Anne Smith, PhD; | Co-Chairs: Anne Smith, PhD; TBD | ||
<br />RSNA Staff Support: Julie Lisiecki | <br />RSNA Staff Support: Julie Lisiecki | ||
Revision as of 16:20, 24 January 2022
Co-Chairs: Anne Smith, PhD; TBD
RSNA Staff Support: Julie Lisiecki
Scope
The NM Coordinating Committee is responsible for:
- Monitoring and coordinating the activities of NM Biomarker Committees
- QIBA Profile Dashboard (NM Page)
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the NM Biomarker Committees
- FDG-PET_Biomarker_Ctte
- PET_Amyloid_Biomarker_Ctte
- SPECT_Biomarker_Ctte
- TC99m Biomarker Committee [page coming soon]
- I-123 Biomarker Committee [page coming soon]
Meetings
- Zoom calls are held Quarterly. Please contact RSNA Staff for details.